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OBJECTIVE—The aim of this study was to reﬁne the informa-
tion regarding the quantitative and spatial dynamics of inﬁltrating
lymphocytes and remaining -cell volume during the progression
of type 1 diabetes in the nonobese diabetic (NOD) mouse model
of the disease.
RESEARCH DESIGN AND METHODS—Using an ex vivo
technique, optical projection tomography (OPT), we quantiﬁed
and assessed the three-dimensional spatial development and
progression of insulitis and -cell destruction in pancreata from
diabetes-prone NOD and non–diabetes-prone congenic NOD.H-2b
mice between 3 and 16 weeks of age.
RESULTS—Together with results showing the spatial dynamics
of the insulitis process, we provide data of -cell volume
distributions down to the level of the individual islets and
throughout the pancreas during the development and progres-
sion of type 1 diabetes. Our data provide evidence for a compen-
satory growth potential of the larger insulin
 islets during the
later stages of the disease around the time point for development
of clinical diabetes. This is in contrast to smaller islets, which
appear less resistant to the autoimmune attack. We also provide
new information on the spatial dynamics of the insulitis process
itself, including its apparently random distribution at onset, the
local variations during its further development, and the forma-
tion of structures resembling tertiary lymphoid organs at later
phases of insulitis progression.
CONCLUSIONS—Our data provide a powerful tool for pheno-
typic analysis of genetic and environmental effects on type 1
diabetes etiology as well as for evaluating the potential effect of
therapeutic regimes. Diabetes 59:1756–1764, 2010
T
ype 1 diabetes is an autoimmune disorder result-
ing from the destruction of insulin-producing
-cells by an autoreactive immune response in-
volving CD4
 and CD8
 T-cells as well as other
leukocyte subsets. Our present understanding of the nat-
ural history of type 1 diabetes (1) depends, to a large
extent, on analysis of rodent models of the disease, like
the nonobese diabetic (NOD) mouse (2). In NOD mice, the
development of clinical diabetes is preceded by an inﬂam-
mation of the pancreatic islets. It is generally thought that
an initial event in triggering the development of insulitis
and -cell destruction is the processing of -cell antigens
by macrophages and dendritic cells residing in the pancre-
atic islets (3). The antigen-presenting cells are then
drained to the pancreatic lymph nodes where they will
present the antigen to autoreactive T-cells. In the absence
of proper peripheral tolerance mechanisms, this leads to
activation and insufﬁciently controlled expansion of these
T-cell clones and eventually to their migration back to the
pancreatic islets, where they mediate -cell destruction
(4). While it is well established that the insulitis progresses
over an extended time period, detailed information on the
quantiﬁcation of spatial dynamics is largely lacking, in
part, due to limitations in existing technology.
Recently, we have developed an optical projection to-
mography (OPT)-based approach (5), allowing for ex vivo,
global evaluation of molecularly labeled pancreatic con-
stituents (e.g., insulin-producing islet cells or inﬁltrating
CD3
 T-cells) (6,7). This provides a method for direct
quantiﬁcation and three dimensional–spatial assessment
of both inﬁltrating lymphocytes and remaining -cell mass
during the progression of type 1 diabetes in NOD mice.
Using this approach to extract information of islet num-
ber, -cell distribution, and volume down to the level of
individual islets throughout the pancreas, we provide a
detailed account of the kinetics and spatial extension of
the insulitis and -cell mass destruction process during the
development and progression type 1 diabetes.
RESEARCH DESIGN AND METHODS
NOD.Bom mice were originally obtained from Bomholtgaard (Ry, Denmark),
while NOD.B10-H-2b (NOD.H-2b) mice were kindly provided by Dr. Linda
Wicker, (Cambridge University, Cambridge, U.K.). Mice were bred and main-
tained in the animal facility at Umeå University. All animals were kept on
normal diet, and the NOD mice were screened for diabetes by urine analysis
for signiﬁcant glucosuria once a week (BM-test Glucose; Boehringer Mann-
heim, Mannheim, Germany). Positive results were thereafter veriﬁed by daily
urine analyses for a week. In our NOD colony, the frequency of diabetes
reached 70% in females and 20% in males by 30 weeks of age. All experiments
were performed in compliance with the relevant Swedish and institutional
laws and guidelines.
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1756 DIABETES, VOL. 59, JULY 2010 diabetes.diabetesjournals.orgOrgan preparations. Pancreata from female NOD and NOD.H2-b mice were
isolated, stained for insulin, and prepared for OPT scanning, as described
previously (6). To minimize variation in the staining procedure, groups
consisting of one pancreas at each time point were stained simultaneously.
For practical reasons, the gastric and duodenal lobe of the pancreas was
scanned as one body (referred to as duodenal) and the splenic lobe as the
other. For studies of insulitis, the same protocols were applied with the
addition of Rb anti-CD3 (C7930; Sigma) primary and Alexa 488 anti-Rb
(Molecular Probes) secondary antibodies.
OPT. OPT scanning using the Bioptonics 3001 OPT scanner (Bioptonics), with
exciter D560/40 and emitter E610lpv2 ﬁlter (Chroma) or exciter D480/30 and
emitter HQ535/50 ﬁlter (Chroma) when visualizing Alexa 594 and 488,
respectively, was performed as described previously (7). Generation of
tomographic reconstructions and quantitations were performed as described
previously (7). Iso-surface reconstructions were generated using the visual-
ization software module for Volocity version 4.3.2 (Improvision). To correct
for minute-zoom factor aberrations detected in the Bioptonics 3001 OPT
scanner, the OPT alignment pin (Bioptonics) was measured with a digital
caliper. This value was compared with digital measurements of the (same)
scanned alignment pin using Skyscan Software (SkyScan). All measurements
were made in triplicate. A correction factor for each magniﬁcation was
calculated by dividing the value obtained with the caliper measurement by the
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FIG. 1. Islet -cell distribution over time in NOD.H-2b and NOD mice. A–J: Isosurface rendered OPT images of representative NOD.H-2b splenic
(A–E), duodenal (A–E), and NOD splenic (F–J) and duodenal (F–J) pancreata labeled for insulin (red). The pancreas outline (gray) is based
on the signal from tissue autoﬂourescense. In contrast to NOD.H-2b mice (A–E), the expected progressive destruction in islet -cell volume is
clearly observed in NOD mice (F–J). Scale bar corresponds to 2.3 mm in I; 2.1 mm in C;2m mi nD, D, J, J, and G; 1.9 mm in B and H; 1.8 mm
in I and H; 1.7 mm in C and E; 1.6 mm in A, E, and F; 1.5 mm in G; 1.4 mm in A and B; and 1.2 mm in F. (A high-quality color representation
of this ﬁgure is available in the online issue.)
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JULY 2010 1757value obtained using the SkyScan software. Volume measurements were
subsequently adjusted according to the calculated correction factors.
Immunohistochemistry and morphometric analysis. Regions of interest
(ROIs) containing 1 of the 10 largest islets were identiﬁed from the
OPT-scanned specimen, as described previously (7). ROIs were isolated,
remaining agarose was removed by washing in 0.29 mol/l sucrose at 57°C, and
processed for cryosectioning. Freshly dissected pancreata from 14-week-old
female NOD mice were ﬁxed with 4% paraformaldehyde in PBS, washed in
PBS, and stored in 30% sucrose at 4°C before snap freezing in OCT compound
(VWR International) and sectioning. Antibodies used were Rb anti-CD3
(C7930; Sigma), Rb anti–phospho-histone H3 (Ser10; Millipore), Rb anti-
glucagon (B31-1; Euro-Diagnostica), Rt anti–MAdCAM-1 (MECA-89; BD
Pharmingen), Rt anti-CD19 (1D3; BD Pharmingen), goat anti-Rb (A11008;
Molecular Probes), goat anti-Rb (A11012; Molecular Probes), and goat anti-Rt
(A11007; Molecular Probes).
Nuclei covering a total -cell area of at least 12,500 m
2 were scored from
12- and 16-week-old female NOD and NOD.H2b mice using a grid covering
2,500 m
2. Average -cell area was calculated by dividing the total -cell area
by the number of nuclei scored.
Statistical analyses. Different zoom factors were used during the OPT
scanning to enable imaging of various-sized pancreata (a pancreas at 16 weeks
is approximately four times larger than at 3 weeks). Hence, the smallest
detectable object (highest resolution) varies between the largest and smallest
pancreas analyzed. To normalize the smallest islet -cell volume analyzed,
between the time series, islet -cell volumes smaller than the smallest
detectable object using the lowest zoom factor were excluded from the
statistical analyses. Therefore, only islet -cell volumes 5,000 m
3 were
analyzed. This volume corresponds to a spherical object with a diameter of
21 m. The excluded islets, even at the highest zoom factor, contributed
only marginally to the overall islet number (9% at 3 weeks) and volume
(0.08% at 3 weeks). Subsequent statistical analyses were performed using
Excel 2007 software (Microsoft). Mann-Whitney U nonparametric (two-tailed)
test in SPSS 16.0 (SPSS, Chicago, IL) was used to compare islet numbers and
volumes between the different stages. The level of signiﬁcance was considered
to be P  0.05. Individual islet -cell volumes, corresponding spatial coordi-
nates, and tomographic scan data ﬁles can be accessed via Web link.
RESULTS
Pancreata from diabetes-prone NOD mice and non–diabe-
tes-prone NOD.H-2b congenic mice were isolated at differ-
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FIG. 2. NOD -cell decay by islet -cell volume size categories. A–E: Isosurface rendered OPT images of representative islet -cell distributions in 3-,
6-, 8-, 12-, and 16-week-old NOD mice (splenic lobe). Individual islet -cell volumes are reconstructed based on the signal from insulin-speciﬁc
antibodies and have been pseudo colored to highlight the distribution of large (>5  106 m
3 [yellow]), intermediate (1–5  106 m
3 [red]), and small
(<1  106 m
3 [white]) islets. Scale bar in corresponds to 2 mm in E, 1.9 mm in C, 1.8 mm in D, 1.5 mm in B, and 1.2 mm in A. F: Graph illustrating
the progressive loss of Ins islets in 3- to 16-week NOD pancreas (duodenal and splenic) broken down to size categories. The values on the y-axis
corresponds the 10 log value of the average number of Ins islets within each size category  SE. The numbers on each bar corresponds to the average
number of Ins islets within each size category. G: Graph illustrating individual variations in total pancreatic -cell volume in NOD mice at 3, 6, 8, 12,
and 16 weeks. Relatively unaffected individuals (black bars) with a total -cell volume over 12  109 m
3 (red line) can be identiﬁed at both 12 and
16 weeks. n  5 for 3, 6, 8, and 16 weeks and n  4 for 12 weeks. Signiﬁcance levels for the decay of -cell volume and number of islets are indicated.
*P < 0.05; **P < 0.01. (A high-quality color representation of this ﬁgure is available in the online issue.)
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1758 DIABETES, VOL. 59, JULY 2010 diabetes.diabetesjournals.orgent ages, ranging from 3 to 16 weeks; stained with anti-
insulin antibodies; and subjected to OPT scanning. In this
manner, the volume of insulin-producing -cells in each
individual islet could be directly quantiﬁed as well as
spatially assessed. As illustrated in Fig. 1, the pancreata
from NOD.H-2b mice displayed islets containing insulin-
producing -cells scattered over the whole organ, with a
similar pattern observed at all ages studied (Fig. 1A–E).
The global assessment of the three dimensional–spatial
distribution also conﬁrmed the previous notion (6,8) of an
uneven distribution of differently sized islets, with a pre-
dominance of small islets in the periphery of the organ and
larger islets mainly located centrally in proximity to the
large blood vessels and pancreatic ducts (Figs. 1 and
2A–E). The total pancreas volume (Fig. 3A and D) in-
creased over the whole period of observation, with the
largest increase occurring between 3 and 8 weeks of age.
A similar development was seen in both NOD and
NOD.H-2b congenic mice, as illustrated by both strains
displaying a similar total pancreas volume at 16 weeks of
age (compare Fig. 3A and D). The total -cell volume
increased with similar kinetics (Fig. 3B and E). In contrast,
the total number of islets (Fig. 3C and F) had reached adult
levels of 2,000 islets at only 3 weeks, agreeing with
previous estimates using stereological techniques (9).
These data suggest that the observed increase in -cell
volume between 3 and 8 weeks of age is mainly due to the
expansion of already-existing islets rather than through de
novo establishment.
In contrast to NOD.H-2b mice, the diabetes-prone NOD
mice displayed an expected loss of ins
 islets due to the
autoimmune process, which became evident at 8 weeks
of age. Between 8 and 12 weeks of age, the average
number of islets decreased by 35%, and between 8 and 16
weeks of age the number of islets was reduced by 75%
(Fig. 3C and F). Interestingly, the drop in islet number was
not accompanied by a corresponding drop in total -cell
volume, which was only reduced by 20% between 8 and
12 weeks and to 50% between 8 and 16 weeks of age (Fig.
3E). This discrepancy could, in part, be explained by the
fact that smaller islets were preferentially lost in the
earlier stages of the process (Fig. 1F–J). To conﬁrm this
notion, we classiﬁed all individual islets into size catego-
ries arbitrarily chosen to represent “large” (5  10
6
m
3), “intermediate” (1–5 10
6 m
3), and “small” (1 
10
6 m
3) islets (Fig. 2) and determined at each time point,
the number of ins
 islets and the mean islet -cell volume
for each of these categories. As illustrated in Fig. 2F, the
maximum number of islets in each size category was
established at 3 weeks for the smallest category and by 6
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FIG. 3. A and D: Graphs showing the average whole-pancreas volume (duodenal and splenic) at 3, 8, and 16 weeks and in NOD.H-2b mice (A) and
in NOD mice (D) at 3, 6, 8, 12, and 16 weeks. B and E: Average total pancreatic -cell volume in NOD.H2-b (B) and NOD (E) mice. C and F: Average
islet number in NOD.H2-b (C) and NOD (F) mice. n  5 for NOD at 3, 6, 8, and 16 weeks, n  4 for NOD at 12 weeks, and n  3 for NOD.H-2b
at 3, 8, and 16 weeks. Values are given  SE. Signiﬁcance levels for the decay of -cell volume and number of islets are indicated. *P < 0.05; **P <
0.01.
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the number of small islets signiﬁcantly decreased (39%,
P  0.05), and between 8 and 16 weeks of age, this
reduction was even more prominent (82%, P  0.01). In
contrast, the number of intermediate and large islets
remained comparatively constant between 8 and 12
weeks. After this point, a clear reduction in the number of
intermediate-sized islets was observed at 16 weeks (77%
reduction when compared with 8 weeks, P  0.01), while
the number of the largest islets, even at this point, only
decreased by 28% when compared with those at 8 weeks.
Together, these data reveal that the smallest, peripherally
located islets are the ﬁrst to be destroyed during insulitis
induced type 1 diabetes.
The time of onset for diabetes in the NOD mouse is
known to display a large individual variation. This is also
reﬂected in the variation in -cell volume of individual
animals. As illustrated in Fig. 2G, the total -cell volume is
kept relatively stable in all animals between 6 and 12
weeks of age, with the exception of one 12-week-old
mouse in which a clear reduction was evident. In contrast,
four of ﬁve 16-week-old mice displayed a similar reduction
in -cell volume, while one mouse appeared relatively
unaffected. Diabetes has been suggested to induce -cell
regeneration either trough recruitment of progenitor cells
from the ductal epithelium or through proliferation of
mature insulin-producing -cells (10–12). It is therefore
possible that in addition to a preferential loss of smaller
islets, the delay in -cell volume reduction when com-
pared with the reduction of islet numbers could be a result
of -cell regeneration. We reasoned that if regeneration of
-cells through proliferation, and/or expansion, of mature
-cells would contribute to this phenomenon, the islets
remaining in later stages of insulitis would be predicted to
increase in volume. To test this hypothesis, we calculated
the average -cell volume of the 10 largest islets in 6- and
8-week-old mice and compared it with the average of the
10 largest islets in the 12- and 16-week-old mice that did
not yet show evidence of reduction in the total -cell
volume (Fig. 2G, ﬁlled bars). The average volume of the
largest NOD islets increased 19% from 6- to 12- and
16-week-old animals (P  0.05), supporting the notion that
regeneration of -cells is parallels the autoimmune de-
struction at this stage of the process (Fig. 4A). The islets in
NOD.H2-b mice were larger than in NOD mice at 8 weeks
of age, but no increase in the average volume of the 10
largest islets could be observed between 8 and 16 weeks
(Fig. 4B). Together, these data indicate that the largest islets
possess a potential for compensatory -cell proliferation
and/or expansion to withstand the autoimmune destruction.
To test for the possibility that the observed expansion could
be due to “swelling” of individual -cells rather than to
proliferation, we determined the average -cell volume in
islets isolated from 12- and 16-week-old NOD or NOD.H2-b
congenic mice. In both cases, the estimated average -cell
area was similar (NOD 12 weeks: 85.6 m
2, NOD 16 weeks:
75.5 m
2, NOD.H2-b 12 weeks: 76.5 m
2, and NOD.H2-b 16
weeks: 81.1 m
2), providing no evidence in support of a
hypermorphic alteration of the NOD -cells.
We next estimated the threshold of total -cell volume
required to withstand the development of overt diabetes
(Fig. 5). Five sibling pairs of NOD origin were analyzed at
the point when one of the individuals (in each litter)
developed overt diabetes, while the other retained normal
glucose levels. The diabetic mice displayed consistently
lower total -cell volume when compared with their
nondiabetic littermates and conﬁrms our previously re-
ported estimates (6) of a threshold at 2.7  10
9 m
3,
below which the mice developed clinical diabetes (Fig.
5C). When compared with 16-week-old NOD.H-2b mice, this
corresponds to an 86% reduction in -cell volume. These
data suggest that the diabetic phenotype of NOD mice
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FIG. 4. A: Graph showing the average volume of the 10 largest islet-cell volumes in 6- and 8- and 12- and 16-week-old NOD mice (in the latter group
only animals with a total pancreatic -cell volume over 12  109 m
3 indicated by ﬁlled bars in Fig. 2G were included). The average size of the
10 largest islet -cell volumes increase from 6 to 16 weeks (P  0.011). n  5 for 6 and 8 weeks and n  4 for 12 and 16 weeks. B: Graph showing
the average volume of the 10 largest islet-cell volumes in 8- and 12- and 16-week-old NOD.H-2b mice.
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been previously reported by point-counting morphometry
(13). It is also worth noting that the approximate threshold
for development of clinical diabetes established in our study
falls well within the estimated interval of a 80–95% reduction
in -cell mass for human type 1 diabetes (14).
We next compared the ﬂuctuations in -cell volume and
islet numbers with the progression of autoimmunity in the
NOD mice. Pancreata isolated at the same ages as ana-
lyzed above were stained with antibodies against insulin
and CD3 to detect -cells and inﬁltrating T-cells and were
submitted to OPT analysis (Fig. 6). Using this method, we
could assess the progression of inﬁltrating CD3
 T-cells
paralleling the progressive loss of -cell mass. In agree-
ment with previous observations (15), the ﬁrst detectable
CD3
-inﬁltrating cells were already present in NOD pan-
creata at 3 weeks of age, progressively increasing in
abundance over time. Surprisingly, the preferential deple-
tion of peripherally located islets was not found to coin-
cide with a preferential insulitis developing in these areas
of the organ. Instead, the appearance of the ﬁrst CD3
 foci
do not appear to occur in any preferred region of the
organ; however, to what extent it follows different blood
vessels or ducts has not been addressed here. A plausible
explanation for this observation is that the destruction of
the small islets in the periphery of the organ occurs more
rapidly because they contain relatively few -cells. As a
consequence of this, the -cell antigen disappears more
rapidly and the inﬁltrating mononuclear cells are no longer
retained at the location of the islet. Like unaffected islets,
the islets displaying severe insulitis were surrounded by
-cells. Thus, while the -cells eventually were destroyed
also in the larger islets affected by insulitis, no correspond-
ing reduction in -cells was observed (Fig. 7).
At later stages, as the individual foci grew in size, the
distribution was less evenly spread over the organ, with
some areas of large accumulations of inﬁltrating cells
present at the same time as other areas of the organ
appearing to be totally unaffected by the inﬂammatory
process. From 8 to 12 weeks, larger accumulations of
CD3
 cells in direct association with islets became evi-
dent. These structures resembled tertiary lymphoid organs
(TLOs), with formation of T- and B-cell areas and of high
endothelial venules (Fig. 6F and G), previously reported to
be associated with chronic inﬂammatory diseases (16)
including in the NOD mouse (17).
DISCUSSION
Using a novel tomographic imaging approach to analyze
the postweaning development of the pancreas in mice, we
have provided detailed three dimensional–spatial and
quantitative data regarding the progession of autoimmune-
induced insulitis and -cell destruction in isolated pancre-
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While this model has been intensively studied using con-
ventional immunohistological methodology, our approach,
by enabling directly quantitative and three dimensional–
spatial analyses of complete intact organs, gives a more
comprehensive picture including a set of novel insights
that will aid in understanding the molecular and cellular
basis of disease progression in this system.
The observed growth kinetics of the endocrine pancreas
in normal mice is not surprising, nor is the progressive loss
of -cell volume observed in the diabetes-prone NOD mice
after massive insulitis has been established. However, the
kinetics of the decrease in islet numbers and loss of -cell
volume, together with the ﬁnding that the mean -cell
volume of the largest and most resistant islet actually
increases, is noteworthy. In fact, this observation provides
evidence of a regenerative process simultaneously under-
way with the autoimmune-induced destruction of -cells.
This has been previously suggested based on the detection
of markers associated with -cell development reoccur-
ring during the autoimmune destruction of -cells in type
1 diabetes (13). This is also in line with recently reported
ﬁndings that abolishment of mature -cells and insulin
expression triggers the regeneration of -cells mainly due
to the expansion of already existing mature -cells (11).
Thus, while we cannot rule out the possibility that the
observed expansion of the large islets in the late stage of
insulitis could, in part, be the result of -cell swelling,
these ﬁndings support the hypothesis that two competing
processes are simultaneously ongoing in the autoimmune
type 1 diabetes pancreas, one of autoimmune destruction
and the other of regeneration of -cells. Understanding the
basic mechanisms controlling these processes remains an
important challenge, with potential implications for inter-
fering and halting the destructive arm of autoimmune
diabetes. The observed formation of TLOs in stages of
advanced insulitis may provide a clue for understanding
how this is controlled. The role of these structures, which
have been reported to appear in various conditions of
chronic inﬂammation (16), could be to sustain autoagres-
sive insulitis, tipping the balance in favor of degeneration
rather than regeneration of the -cells. Further insights
into when and how these structures are formed in associ-
ation with insulitis, together with a better understanding
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tion, is much warranted and should shed light on how to
interfere with the progression of insulitis and -cell de-
struction. Another interesting observation is the unsyn-
chronized spreading of insulitis into different parts of the
organ. In view of the prevailing model for the onset and
progression of insulitis, the observed coexistence of areas
with full-blown insulitis adjacent to areas apparently un-
affected by insulitis is remarkable and suggests that local
factors may provide cues for the homing of activated
lymphocytes back to the pancreas.
The quantitative and three dimensional–spatial charac-
terization of the autoimmune progression, from the earli-
est stages of leukocyte inﬁltration into the endocrine
pancreas to the complete destruction of the -cell volume
and development of diabetes, provides a novel and more
detailed frame of the process that could be used for
elucidating the effect of speciﬁc genetic factors (e.g., by
comparing NOD mice with transgenic or congenic strains)
and for efﬁcient evaluation of various treatment protocols.
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